MoonLake Immunotherapeutics Financial Flexibility Index
MoonLake Immunotherapeutics financial flexibility index. MoonLake Immunotherapeutics (MLTX) has a Financial Flexibility Index of -0.45x as of March 2026. Free cash flow of $-66.29 Million (operating CF $-66.29 Million minus capex $0.00) represents 0% of total liabilities ($146.35 Million). See MoonLake Immunotherapeutics free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MoonLake Immunotherapeutics (2020–2025)
Financial flexibility index of MoonLake Immunotherapeutics from 2020 to 2025. Historical Financial Flexibility Index trend for MoonLake Immunotherapeutics across 6 annual periods. Explore MLTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
MoonLake Immunotherapeutics Financial Flexibility Index by Year (2020–2025)
MoonLake Immunotherapeutics financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for MoonLake Immunotherapeutics. For the full cash flow conversion analysis, see MoonLake Immunotherapeutics (MLTX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.63x | $-195.97 Million | $-196.01 Million | $119.95 Million | ▲ +65.5% |
| 2024 | -4.73x | $-116.07 Million | $-116.59 Million | $24.54 Million | ▼ -45.2% |
| 2023 | -3.26x | $-42.49 Million | $-42.78 Million | $13.05 Million | ▲ +52.9% |
| 2022 | -6.92x | $-55.88 Million | $-55.89 Million | $8.08 Million | ▼ -320.1% |
| 2021 | -1.65x | $-35.12 Million | $-35.18 Million | $21.33 Million | ▼ -2058.2% |
| 2020 | -0.08x | $-316.69K | $-316.69K | $4.15 Million | — |